FRMS CO., LTD(SZ:300049) Xin Lang Cai Jing·2026-01-14 07:18Group 1 - The core point of the news is that Furuimei Medical has seen a continuous increase in its stock price, rising 0.79% to 84.15 CNY per share, with a total market capitalization of 22.298 billion CNY and a cumulative increase of 16.39% over the past six days [1] - Furuimei Medical, established on December 26, 2001, and listed on January 20, 2010, is primarily engaged in the production and sales of drugs in the liver disease sector, as well as the research and sales of medical instruments and medical services [1] - The company's revenue composition is as follows: 67.57% from equipment and technology, 27.47% from pharmaceuticals, 4.30% from medical services, and 0.65% from other sources [1] Group 2 - According to data from the top ten holdings of funds, one fund under E Fund has a significant position in Furuimei Medical, with the E Fund Growth ETF (159572) holding 83,800 shares, representing 0.97% of the fund's net value [2] - The E Fund Growth ETF has generated a floating profit of approximately 55,300 CNY today and a total of 993,000 CNY during the six-day increase [2] - The E Fund Growth ETF was established on December 15, 2023, with a current scale of 644 million CNY and has achieved a year-to-date return of 11.1%, ranking 566 out of 5,520 in its category [2]